Success Metrics

Clinical Success Rate
80.0%

Based on 16 completed trials

Completion Rate
80%(16/20)
Active Trials
2(7%)
Results Posted
25%(4 trials)
Terminated
4(15%)

Phase Distribution

Ph early_phase_1
3
11%
Ph not_applicable
6
22%
Ph phase_1
2
7%
Ph phase_3
2
7%
Ph phase_4
9
33%
Ph phase_2
4
15%

Phase Distribution

5

Early Stage

4

Mid Stage

11

Late Stage

Phase Distribution26 total trials
Early Phase 1First-in-human
3(11.5%)
Phase 1Safety & dosage
2(7.7%)
Phase 2Efficacy & side effects
4(15.4%)
Phase 3Large-scale testing
2(7.7%)
Phase 4Post-market surveillance
9(34.6%)
N/ANon-phased studies
6(23.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

16 of 20 finished

Non-Completion Rate

20.0%

4 ended early

Currently Active

2

trials recruiting

Total Trials

27

all time

Status Distribution
Active(3)
Completed(16)
Terminated(4)
Other(4)

Detailed Status

Completed16
Terminated4
unknown4
Recruiting2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
27
Active
2
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (11.5%)
Phase 12 (7.7%)
Phase 24 (15.4%)
Phase 32 (7.7%)
Phase 49 (34.6%)
N/A6 (23.1%)

Trials by Status

not_yet_recruiting14%
completed1659%
recruiting27%
terminated415%
unknown415%

Recent Activity

Clinical Trials (27)

Showing 20 of 27 trialsScroll for more
NCT05282277Phase 4

Examining the Effects of Estradiol on Neural and Molecular Response to Reward

Recruiting
NCT03068910Early Phase 1

Hyperandrogenemia and Altered Day-night LH Pulse Patterns

Recruiting
NCT06856174Phase 4

Menopausal HT for Women Living With HIV (HoT)

Not Yet Recruiting
NCT03642665Phase 4

Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer

Completed
NCT03976544Phase 4

Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients

Terminated
NCT04758871Phase 4

Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles

Completed
NCT04597099Early Phase 1

Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion

Unknown
NCT05997563Phase 4

Adjunctive Vaginal Progesterone in Management of Preterm Labor

Unknown
NCT04051320Phase 2

Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model

Completed
NCT04108039Not Applicable

Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles.

Completed
NCT04225221Phase 2

Neurobiology of Bulimia Nervosa

Completed
NCT04753957Phase 1

Pharmacokinetics of Progesterone in Pregnancy-2

Terminated
NCT03998761Not Applicable

Progesterone Versus Progesterone Plus Dydrogesterone in FET

Completed
NCT03677336Phase 4

Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI

Completed
NCT03774745Phase 1

Blocking Mifepristone Action With Progesterone

Terminated
NCT02486757Early Phase 1

Investigation of Female Reproductive Hormone Dynamics During Adolescence

Completed
NCT03309735

Non-interventional Study of Therapy for Threatened Miscarriage

Completed
NCT02989519Phase 3

Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm Labor

Completed
NCT02329535Not Applicable

Comparing Double Dose of Vaginal Progesterone to no Treatment for Prevention of Preterm Birth in Twins and Short Cervix

Terminated
NCT02086032Not Applicable

The Effect of Different Types of Progestin on Sleeping of Menopausal Women

Completed

Drug Details

Intervention Type
DRUG
Total Trials
27